Press Release Neumora Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update Aug 14
Press Release Neumora Therapeutics Reports Favorable NMRA-215 Toxicology Results with Planned Clinical Advancement in 2026 Jul 27